YunFu Hu - Genetron Holdings Chief Officer

Insider

YunFu Hu is Chief Officer of Genetron Holdings
Age 61
Phone86 10 5090 7500
Webhttps://www.genetronhealth.com

Genetron Holdings Management Efficiency

The company has Return on Asset of (0.352) % which means that on every $100 spent on assets, it lost $0.352. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.922) %, meaning that it generated no profit with money invested by stockholders. Genetron Holdings' management efficiency ratios could be used to measure how well Genetron Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
Genetron Holdings has 158.57 M in debt with debt to equity (D/E) ratio of 0.18, which may show that the company is not taking advantage of profits from borrowing. Genetron Holdings has a current ratio of 2.77, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Genetron to invest in growth at high rates of return.

Similar Executives

Showing other executives

INSIDER Age

Ryan DouglasExagen Inc
N/A
Kristin GibbsSotera Health Co
N/A
Ryan SiurekBiodesix
52
Robert CawthornBiodesix
87
Bobbi CoffinBiodesix
N/A
Kevin TheriaultSotera Health Co
N/A
James LoeropAclaris Therapeutics
60
Zvi DavidDarioHealth Corp
63
Jeffrey BojarBiodesix
N/A
John AbbottCastle Biosciences
N/A
Debra ZackExagen Inc
65
William PitchfordInotiv Inc
69
Richard AndersonDarioHealth Corp
55
Camilla ZuckeroCastle Biosciences
N/A
Paul ChangelianAclaris Therapeutics
N/A
MBA MBASera Prognostics
70
Robert HarrisonSera Prognostics
59
Ron KalfusMDxHealth SA ADR
50
Michael PetrasSotera Health Co
56
Michael BiehlSotera Health Co
68
Robert HauzieSotera Health Co
N/A
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the Peoples Republic of China. Genetron Holdings operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1154 people. Genetron Holdings (GTH) is traded on NASDAQ Exchange in USA and employs 993 people.

Management Performance

Genetron Holdings Leadership Team

Elected by the shareholders, the Genetron Holdings' board of directors comprises two types of representatives: Genetron Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genetron. The board's role is to monitor Genetron Holdings' management team and ensure that shareholders' interests are well served. Genetron Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genetron Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Hai MD, Chief CoFounder
Sizhen Wang, CEO CoFounder
Ce Xu, Chief Officer
Hai Yan, Chief CoFounder
Lily Liu, Chief Officer
YunFu Hu, Chief Officer
Yuchen MD, Chief Officer
WeiWu He, CoFounder Emeritus
Yong Liang, Chief Officer
Victoria Lei, Chief Officer

Genetron Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genetron Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Genetron Stock

If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk